吉利汽車(00175.HK)旗下極氪申請美國IPO 上半年收入29.3億美元
吉利汽車(00175.HK)旗下新能源車品牌極氪(Zeekr)周四(9日)向美國證交會申請首次公開發行股票上市。
在中國和紐約均設有辦事處的極氪表示,計劃在紐約證券交易所上市,股票代號為ZK。該公司並未透露將發行多少股票上市。
極氪表示,公司2022年營收為44億美元,虧損10.5億美元。截至6月30日的六個月,公司營收為29.3億美元,虧損5.3378億美元。該公司打算將此次發行的收益用於開發更先進的純電動車技術,並擴大其產品組合,亦將用於銷售和行銷、擴展其服務和充電網絡,以及一般企業用途並支持其成長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.